Across developing countries, there is a staggering gap between healthcare needs and available resources. According to the latest WHO-World Bank report, 2 billion people worldwide face financial hardship due to healthcare costs, while the situation in sub-Saharan Africa is particularly acute: the continent imports a significant majority of its pharmaceuticals, leaving it highly vulnerable to global supply chain disruptions.
This challenge directly impacts the United Nations Sustainable Development Goal 3 (SDG-3), which aims to ensure healthy lives and promote well-being for all at all ages. The World Health Organisation has identified strengthening health systems as a prerequisite for achieving universal health coverage, emphasising that access to quality-assured essential medicines is a fundamental component.
For Ministries of Health and institutional buyers, these statistics translate into daily challenges - stockouts of essential medicines, unreliable suppliers, and limited budgets that must stretch to cover critical healthcare needs.
The solution lies in strategic partnerships with compliant, reliable pharmaceutical suppliers who understand the unique challenges of public health systems in developing countries.
For government tenders and public health programs, quality is non-negotiable. Substandard medicines not only fail patients but also waste scarce resources and erode trust in healthcare systems. This is why WHO-GMP certifications have become the global gold standard for pharmaceutical suppliers.
Caritas Healthcare's facilities are approved by leading regulatory authorities worldwide, demonstrating our ability to comply with the most stringent market requirements:
Regulatory Body
Significance
WHO-GMP
Global benchmark for pharmaceutical quality
EU-GMP
European Union's rigorous manufacturing standards (European Medicines Agency framework)
USFDA
U.S. Food and Drug Administration approval—one of the world's most stringent regulatory frameworks
MHRA-UK
The United Kingdom's Medicines and Healthcare products Regulatory Agency approval
ANVISA Brazil
Brazilian health regulatory approval for Latin America's largest market
The Numbers: With 250+ product registrations across regulated, semi-regulated, and emerging markets, Caritas demonstrates the ability to meet country-specific regulatory frameworks while maintaining consistent quality standards.
Why It Matters: For Ministries of Health, partnering with a WHO-GMP certified supplier, the European Medicines Agency, and the Medicines and Healthcare products Regulatory Agency means faster market access, reduced regulatory hurdles, and guaranteed product quality for national health programs.
In developing countries, out-of-pocket spending on medicines remains the primary driver of financial hardship related to healthcare. Generic medicines offer the most direct path to affordability.
Caritas' Manufacturing Capabilities:
Production Capacity
Annual Output
Tablets
1000 Million
Capsules
350 Million
Injectables
100 Million
Liquids
250 Million
Sachets
Beyond production numbers, these capabilities translate into meaningful public health impact:
Supporting treatment access for millions of patients across 20+ countries
Enabling national health programs to serve larger populations with limited budgets
Reducing out-of-pocket burden for vulnerable communities
Our diverse portfolio spans anaesthesiology, cardiology, dermatology, endocrinology, gastroenterology, haematology, immunology, and infectious diseases—addressing the conditions that place the heaviest burden on public health systems in developing countries.
A Ministry of Health in South America faced recurring stockouts of essential cardiovascular and endocrine medications, with supply chain disruptions causing treatment interruptions for patients with hypertension and diabetes.
Through our subsidiary in Ecuador and strategic warehouse in Guayaquil, Caritas established a dedicated supply channel:
Local warehouse stock ensured buffer inventory for rapid replenishment
In-country regulatory team expedited product registrations
Tender support enabled consistent participation in public procurement
Reduced delivery timelines from 12 weeks to 3 weeks
Zero stockouts of contracted essential medicines over two years
Expanded patient access to quality-assured cardiovascular and diabetes treatments
This hybrid model—global manufacturing combined with local presence—demonstrates how pharmaceutical partners can move beyond transactions to build resilient healthcare systems.
Sustainable healthcare improvement requires more than just delivering medicines. It requires building local capacity to manage, distribute, and utilise those medicines effectively.
Caritas Healthcare’s Local Footprint:
Region
Countries with Subsidiaries
Africa
Kenya, Uganda, Tanzania
Latin America
Mexico, Ecuador, Dominican Republic, Guatemala
Asia
Singapore, Philippines
South Asia
India (Headquarters)
What Local Presence Enables:
Capability
How It Strengthens Health Systems
Knowledge Transfer
Local teams work alongside health ministries to understand country-specific challenges and develop tailored solutions
Supply Chain Integration
Strategic warehouses in Mexico, Ecuador, and India ensure faster market access and seamless reach in both private and public (tender) markets
Training and Support
Comprehensive training for distributors ensures proper storage, expiry monitoring, and regulatory compliance
Regulatory Navigation
In-country teams manage local registrations and maintain relationships with health authorities
The Result: End-to-end global logistics through integrated sales, marketing, warehousing, and distribution networks, backed by local teams in each country.
The COVID-19 pandemic exposed the dangers of overreliance on fragmented, transactional supply relationships. Building resilient healthcare systems requires robust supply chains with built-in redundancy and real-time visibility.
Six Manufacturing Capable Plants strategically located across India's leading pharma hubs:
Baddi, Solan (Himachal Pradesh)
Kadi, Mehsana (Gujarat)
Vatva, Ahmedabad (Gujarat)
Panchkula (Haryana)
Vapi GIDC (2 plants, Gujarat)
Advanced Supply Chain Capabilities:
Implementation
Digital Supply Chain Monitoring
Real-time tracking of inventory and shipments across the distribution network
Cold Chain Logistics
Temperature-controlled storage and transport for sensitive products
Demand Forecasting
Data-driven prediction to prevent shortages and optimise inventory levels
Diverse Product Capabilities
Tablets, capsules, syrups, suspensions, injectables, vials, ointments, sachets
Quality Assurance: Every plant adheres to stringent QA/QC systems aligned with global best practices. From raw material to final packaging, every stage undergoes rigorous testing to guarantee safety and quality.
Reliable Distribution & Warehousing: Our robust distribution network ensures medicines reach hospitals, pharmacies, and patients on time, every time. Our strategically located warehouses maintain optimal storage conditions, including cold chain management for temperature-sensitive products.
Why It Matters for Public Health: Real-time inventory monitoring and logistics tracking minimise delays and prevent shortages. This end-to-end reliability strengthens healthcare delivery across developing economies.
The most effective pharma support for public health programs are built on long-term partnerships based on trust, reliability, and shared commitment to community health.
Caritas' Partner Ecosystem:
Partner Type
How We Support
Ministries of Health
Reliable large-scale medicine supplies for national programs; cost-effective procurement; strict quality standards; on-time delivery for government tenders
Hospitals & Healthcare Facilities
Consistent supply of tablets, injectables, liquids, and OTC products; competitive pricing; quality assurance
NGOs & International Organisations
Flexible, responsive supply arrangements that adapt to changing needs on the ground; support for WHO programs and global health initiatives
Distributors
Comprehensive training; full product range access; support for regulatory compliance
Our Commitment to Safety:
Caritas maintains a robust pharmacovigilance system to monitor, assess, and prevent adverse events throughout the lifecycle of our medicines. By working with healthcare providers, regulators, and patients, we continuously evaluate real-world data to identify risks early and take proactive safety measures.
20+ countries served across five continents
150+ professionals worldwide
Operations in regulated, semi-regulated, and emerging markets
Subsidiaries driving full business operations—including regulatory, commercialisation, and supply chain management
Global pharmaceutical communication increasingly emphasises sustainability commitments. At Caritas Healthcare, we integrate responsible practices throughout our operations:
Focus Area
Our Approach
Responsible Manufacturing
Facilities aligned with global environmental standards; waste management protocols
Ethical Supply Chains
Transparent sourcing; supplier audits; fair labour practices
Community Investment
CSR initiatives supporting healthcare access in underserved communities
Patient-Centered Care
"Love for Humankind" philosophy guiding business decisions
Through the Caritas Healthcare Foundation, we support national healthcare programs, provide humanitarian assistance during disasters, and implement patient awareness programs that enable healthier communities built on compassion and care.
Founded in 2012, Caritas Healthcare has grown into a leading global pharmaceutical company with a clear mission: to improve health and save lives by delivering accessible, affordable, and high-quality medications.
What Sets Us Apart:
Differentiator
Caritas Advantage
Regulatory Excellence
WHO-GMP, EU-GMP, USFDA, MHRA-UK, and ANVISA Brazil approvals
Manufacturing Scale
Six world-class plants; 1 billion+ tablets annually
Global Reach
20+ countries; 5 continents; subsidiaries across Africa, Latin America, and Asia
Local Presence
End-to-end logistics; strategic warehouses; in-country teams
Therapeutic Breadth
Comprehensive portfolio covering major disease burdens
Patient Safety
Robust pharmacovigilance; culture of vigilance and accountability
Sustainability
Responsible manufacturing; ethical supply chains; community investment
With only five years remaining on the SDG agenda, urgent action is needed to expand service coverage, reduce financial hardship, and strengthen global health systems in developing countries.
Caritas Healthcare stands ready to support Ministries of Health, procurement agencies, hospital networks, and global distributors in this mission. By combining global expertise with local presence, we provide accessible healthcare solutions that make a meaningful impact, staying true to our mission to improve health and save lives.
At Caritas, we believe collaboration is key to advancing global healthcare. Whether you're a Ministry of Health seeking reliable tender partnerships, a hospital network requiring consistent supply, or an NGO supporting public health programs, we're here to partner with you.
We specialise in:
Large-scale supply agreements
Government tender support
Long-term public health partnerships
Together, we can strengthen healthcare systems in developing countries and ensure that every patient, everywhere, has access to the quality medicines they need.